Related Experiment Video
Updated: May 9, 2026

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
Published on: February 9, 2019
Mineralized cyclodextrin nanoparticles for sustained protein delivery.
Maharajan Sivasubramanian1, Thavasyappan Thambi, Jae Hyung Park
1Department of Advanced Polymer and Fiber materials, Kyung Hee University, Gyeonggi-do 446-701, Republic of Korea.
New cyclodextrin-based polymeric nanoparticles (CD-NPs) mineralized with calcium phosphate offer sustained protein delivery. These nanoparticles protect protein drugs, extending their therapeutic effects and maintaining activity for up to 21 days.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Drug Delivery Systems
Background:
- Protein drugs face limitations due to instability and short in vivo half-lives.
- Sustained delivery systems are crucial for prolonging therapeutic effects of protein drugs.
Purpose of the Study:
- To develop and characterize cyclodextrin-based polymeric nanoparticles (CD-NPs) mineralized with calcium phosphate for sustained protein delivery.
- To evaluate the loading efficiency, release kinetics, and enzymatic activity of a model protein (Carbonic Anhydrase B) from the mineralized CD-NPs.
Main Methods:
- Preparation of spherical CD-NPs using a β-cyclodextrin and carboxymethyl dextran conjugate.
- Mineralization of CD-NPs with calcium phosphate in a physiological solution.
- Characterization of physicochemical properties using FT-IR, TGA, TEM, and XPS.
- Loading of Carbonic Anhydrase B (CAB) via dialysis and in vitro release studies.
Main Results:
- Mineralization reduced CD-NP particle size to 121 nm in PBS (pH 7.4), forming compact nanoparticles.
- High loading efficiency (80%) of CAB was achieved.
- Mineralized CD-NPs exhibited sustained release of CAB for 21 days, compared to 3 days for bare CD-NPs.
- Released CAB retained significant enzymatic activity.
Conclusions:
- Mineralized CD-NPs serve as an effective diffusion barrier, enabling sustained protein release.
- The developed nanoparticles show promise as a carrier for enhancing the therapeutic efficacy of protein drugs.
- This approach offers a viable strategy for overcoming the limitations of protein drug instability and short half-lives.
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Oral Drug Delivery Systems: Continuous-Release Systems
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Modified-Release Drug Delivery Systems: Site-Targeted

